Search

Your search keyword '"Becker, Stephen L."' showing total 13 results
Start Over Author "Becker, Stephen L."
13 results on '"Becker, Stephen L."'

1. An Analysis of Public-Private School Choice in Texas.

Author

Texas Public Policy Foundation, San Antonio., National Center for Policy Analysis, Dallas, TX., Dougherty, J. Chrys, and Becker, Stephen L.

Abstract

This report makes a quantitative and qualitative assessment of four concerns as they apply to school choice in Texas schools: (1) parents of students participating in choice programs select schools for reasons having little to do with academic quality; (2) school-choice plans that allow the use of taxpayer money at private schools will drain resources from the public-school system; (3) there will be few open seats available at private schools that choose to participate in a choice plan; and (4) transportation is a barrier to effective choice plans. The report is divided into four parts: Why Parents Choose Schools; Fiscal Impact of School Choice; Prospects for Private-School Entry; and Access to Transportation. Findings indicate that low-income parents provide widespread support for school choice, that the variable cost of a Texas public-school student is 87 percent to 93 percent of the total annual operating expenses, that the existing supply of private-school vacancies is extremely small in relation to the population of students that will be eligible for school choice, and that transportation will not be a major stumbling block if participating private schools provide the same services as comparable public schools. The document concludes with a strategy for implementing school choice in Texas. Contains 22 references. (RJM)

Published
1995

2. Pharmacokinetics of saquinavir with atazanavir of low-dose ritonavir administered once daily (ASPIRE I) or twice daily (ASPIRE II) in seronegative volunteers

Author

King, Jennifer R., Kakuda, Thomas N., Paul, Sunita, Tse, Man Ming, Acosta, Edward P., and Becker, Stephen L.

Subjects
Saquinavir -- Dosage and administration -- Research, Pharmacokinetics -- Research, Ritonavir -- Dosage and administration -- Research, HIV patients -- Drug therapy, Health, Drug therapy, Research, Dosage and administration
Abstract

ASPIRE I and II were prospective, 3-way sequential crossover studies in healthy volunteers to compare the safety and pharmacokinetics of saquinavir/ritonavir (SQV/RTV) with saquinavir/atazanavir (SQV/ATV) administered either once daily (QD, [...]

Published
2007

3. Zidovudine and stavudine sequencing in IHV treatment planning: findings from the CHORUS HIV cohort

Author

Becker, Stephen L., Raffanti, Stephen R., Hansen, Nellie I., Fusco, Jennifer S., Fusco, Gregory P., Slatko, Gary H., Igboko, Ebere F., and Graham, Neil M.H.

Subjects
HIV infection -- Drug therapy, Zidovudine -- Health aspects, Stavudine -- Health aspects, Health
Abstract

HIV patients should be given zidovudine first, then stavudine, rather than vice versa. This was the conclusion of a study of 940 HIV patients, 834 of whom began with zidovudine and 106 of whom began with stavudine.

Published
2001

9. The Home as a Site for Teaching Gerontology and Chronic Illness.

Author

Sankar, Andrea and Becker, Stephen L.

Abstract

Research findings have demonstrated the relevance of a home care experience for teaching the interactions of the social, psychological, environmental, and biological factors that characterize chronic illness. Research was conducted in the Home Care Program at the University of California, San Francisco. (Author/MLW)

Published
1985

13. Young HIV-infected adults are at greater risk for medication nonadherence.

Author

Becker SL, Dezii CM, Burtcel B, Kawabata H, and Hodder S

Subjects
Adolescent, Adult, Age Factors, Aged, California, Drug Prescriptions statistics & numerical data, Female, Humans, Male, Medicaid statistics & numerical data, Middle Aged, Pharmacy statistics & numerical data, Retrospective Studies, Reverse Transcriptase Inhibitors therapeutic use, Risk Factors, Sex Factors, HIV Infections drug therapy, HIV Infections physiopathology, Patient Compliance statistics & numerical data
Abstract

This study sought to estimate rates of adherence to nucleoside reverse transcriptase inhibitors (NRTIs) during the first year of administration in the California Medicaid (Medi-Cal) population. A retrospective analysis of pharmacy claims data regarding NRTI prescription refills was employed to estimate adherence and persistence with therapy throughout 1 year in treatment-naive individuals. Adherence was defined as the proportion of days on which drugs were taken during the first 365 days of therapy, and persistence was assessed according to whether prescriptions were refilled over time within a tolerable threshold (60 days). A total of 2614 men and 1174 women exhibited a mean overall adherence rate of 53.0%, and 35.6% of individuals were persistent with therapy throughout the year. No differences in persistence or adherence rates by sex were detected (P =.30). The proportion of individuals with adherence of 80% or better was 26%. Age was found to be significant in adherence and persistence by chi-square examination (P =.001). We conclude that nonadherence can be a critical issue during the first year following initiation of therapy. Comprehensive adherence support programs may be required to maximize adherence, especially among subjects aged 18-24 years, and should be made available early in the course of therapy, or before it is initiated.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results